Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia-Reference-Cited by-同舟云学术

Positive response to imatinib mesylate therapy for childhood chronic myeloid leukemia

Published:2010-06 Issue:6 Volume:43 Page:580-584
ISSN:0100-879X
Container-title:Brazilian Journal of Medical and Biological Research
language:
Short-container-title:Braz J Med Biol Res

Author:

Oliveira G.A.P.¹,Costa E.S.²,Freitas M.S.²,Dutra F.F.²,Maia S.F.²,Guerra M.C.²,Tabernero M.D.³,Borojevic R.²,Otazu I.B.⁴,Silva J.L.²

Affiliation:

1. Universidade Federal do Rio de Janeiro, Brasil; Universidade Federal do Rio de Janeiro, Brasil

2. Universidade Federal do Rio de Janeiro, Brasil

3. Hospital Universitario de Salamanca, Spain

4. Universidade Federal do Rio de Janeiro, Brasil; Abu Dhabi, United Arab Emirates (UAE)

Publisher

FapUNIFESP (SciELO)

Subject

Cell Biology,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Immunology,Physiology,Biochemistry,General Neuroscience,Biophysics

Link

http://www.scielo.br/pdf/bjmbr/v43n6/107.pdf

Reference15 articles.

1. Response to alpha-interferon in children with Philadelphia chromosome-positive chronic myelocytic leukemia;Dow LW;Cancer,1991

2. Alpha-interferon in combination with cytarabine in children with Philadelphia chromosome-positive chronic myeloid leukemia;Millot F;J Pediatr Hematol Oncol,2002

3. Treatment of CML in pediatric patients: should imatinib mesylate (STI-571, Gleevec) or allogeneic hematopoietic cell transplant be front-line therapy?;Pulsipher MA;Pediatr Blood Cancer,2004

4. Response and resistance in 300 patients with BCR-ABL-positive leukemias treated with imatinib in a single center: a 4;Lahaye T;5-year follow-up. Cancer,2005

5. Detection of BCR-ABL mutations in patients with CML treated with imatinib is virtually always accompanied by clinical resistance, and mutations in the ATP phosphate-binding loop (P-loop) are associated with a poor prognosis;Branford S;Blood,2003